Category: Ultrasound

Posted on

Intraoperative Ultrasound in Chiari 1 Decompression: Clarity or Confusion?

Neurosurgery 99:19–29, 2026

This systematic review evaluates intraoperative ultrasound (iUS) use in guiding the extent of posterior fossa decompression (PFD versus PFD+) for Chiari malformation type 1, analyzing nine studies (844 patients) for iUS criteria, conversion rates, and positive predictive values. It finds substantial heterogeneity in acquisition, qualitative versus quantitative criteria, and outcome reporting, limiting iUS’s reliability for intraoperative decision making.

The authors propose a standardized reporting framework emphasizing defined CSF space measurements, dynamic metrics (e.g., CSF flow velocity, tonsillar excursion), triplicate measurements with dual raters, and ≥12-month validated outcomes to enable reproducible research and clearer assessment of iUS utility.

Clinical dilemma Bone-only posterior fossa decompression (PFD) is less invasive, while dural opening/expansion (PFD+) may be more effective but has higher complication risk; intraoperative ultrasound (iUS) is used to help decide whether PFD alone is sufficient, but its role/criteria are not defined.

Evidence base 9 studies (1 prospective, 8 retrospective) totaling 844 patients (pediatric and adult) were included; risk of bias was low in 1 study, moderate in 3, and high in 5.

How iUS was applied iUS was used after bony decompression and before dural opening; none of the studies used iUS after opening the dura.

Decision criteria heterogeneity 8 studies used qualitative criteria (e.g., “enough space,” tonsillar pulsation, piston-like motion, bidirectional flow), and 1 study used a quantitative CSF flow-velocity threshold.

Conversion surgery outcomes “Conversion” (later revision from PFD to PFD+ due to persistent/worsening symptoms) occurred in 35/844 patients (5% overall), with study-level conversion rates from 0% to 16%.

Predictive value variability Positive predictive value (PPV) for iUS-guided PFD success ranged from 0.857 to 1.000 across studies, varying with criteria and study design.

Main conclusion Current evidence does not support iUS as a robust intraoperative test for deciding extent of decompression because of heterogeneous application and lack of standardized assessment criteria; sensitivity/specificity cannot be determined with available data structure.

Proposed path forward A standardized reporting framework is proposed, emphasizing defined acquisition parameters, quantitative/operationalized criteria, validated outcome measures, and ≥12-month follow-up to enable comparability and future pooled analyses.

Posted on

Contrast-Enhanced Ultrasound Perfusion Imaging of the Spinal Cord Before and After Surgical Decompression for Cervical Spondylotic Myelopathy

Neurosurgery 98:688–697, 2026

Contrast-enhanced ultrasound (CEUS) was applied intraoperatively to acquire spinal cord perfusion metrics before and after posterior decompression in 16 patients with cervical spondylotic myelopathy (CSM). The study details a reproducible surgical ultrasound window, CEUS acquisition parameters, time–intensity curve analysis, and statistical correlation of wash-in-time (WIT) with modified Japanese Orthopedic Association (mJOA) scores.

The technique proved feasible and safe, yielding pre- and postdecompression perfusion data without complications. Predecompression and postdecompression WIT correlated significantly with preoperative, 1-month, and 6-month mJOA scores, suggesting CEUS WIT may have prognostic utility for postoperative neurologic recovery.

Contrast-Enhanced Ultrasound (CEUS) Feasibility: CEUS can safely and effectively acquire spinal cord perfusion data both before and after surgical decompression in patients with cervical spondylotic myelopathy (CSM).

Wash-In Time (WIT) as Key Perfusion Parameter: WIT, defined as the time between initial appearance and peak concentration of contrast microbubbles, is the most relevant CEUS-derived perfusion metric and inversely correlates with neurologic status measured by modified Japanese Orthopedic Association (mJOA) scores.

Correlation with Neurologic Outcomes: Lower WIT values (indicating faster perfusion) are significantly associated with better preoperative and postoperative neurologic function at 1 and 6 months, suggesting potential as a prognostic biomarker.

No Significant Correlation with MRI Signal Change: Preoperative spinal cord signal changes on MRI, previously considered prognostic, did not correlate with WIT or other perfusion indices in this cohort.

Technical Approach: A small bony trough is created at the lateral lamina border to allow direct insonation of the compressed spinal cord, enabling both pre- and post-decompression CEUS imaging without interfering with standard surgical workflow.

No Major Complications: The technique was free of adverse events related to ultrasound contrast administration or the imaging process itself.

Small Sample and Pilot Nature: The study’s findings are limited by its small sample size (16 patients), and further multicenter, prospective studies are needed to validate CEUS as a predictive tool for surgical outcomes in CSM.

Clinical Implication: CEUS, and specifically preoperative WIT, shows promise for intraoperative prognostication and may help identify patients at risk for poor recovery or reperfusion injury after cervical decompression surgery.

Posted on

A Scoping Review of Focused Ultrasound- Blood-Brain Barrier Opening for Treatment of Chronic Pain

Neurosurgery 98:328–338, 2026

This scoping review evaluates focused ultrasound–mediated blood–brain barrier opening (FUS‑BBBO) as a targeted drug‑delivery strategy to treat chronic pain, summarizing systematic literature screening and preclinical evidence. It outlines how FUS parameters, microbubbles, and regional targeting can transiently permit delivery of drugs and particles otherwise excluded by the BBB, potentially improving efficacy and reducing systemic toxicity.

The document surveys candidate therapeutics (opioids, peptides, antibodies, gene therapies) and particle vehicles (nanoparticles, liposomes, niosomes, AAVs), highlights preclinical successes and delivery challenges, and stresses safety, parameter optimization, and the need for human trials. It concludes that FUS‑BBBO combined with advanced delivery platforms holds promise but requires systematic clinical evaluation.

Blood-brain barrier (BBB) challenge: The BBB restricts most drugs from entering the brain, impeding effective pharmacological treatment of chronic pain, with only small, lipophilic molecules (<400–500 Da) able to cross easily, while 98% of small molecules and nearly all large molecules are excluded.

Focused ultrasound (FUS)-mediated BBB opening (FUSBO): FUSBO uses low-intensity ultrasound and microbubbles to temporarily, noninvasively open the BBB, enabling targeted drug delivery to specific brain regions without thermal damage.

Current pain therapies’ limitations: Opioids, gabapentin, cannabinoids, and other agents have limited efficacy and significant systemic side effects due to poor BBB penetration and susceptibility to efflux mechanisms like p-glycoprotein pumps.

Preclinical evidence, lack of human trials: While FUSBO has shown success in animal models for delivering pain therapies directly to the CNS and enhancing efficacy, no human studies have yet assessed FUSBO for chronic pain treatment.

Advancements in drug delivery particles: Nanoparticles, niosomes, polymeric nanoparticles, gold nanoparticles, and liposomes can be engineered to carry drugs across the BBB, improve bioavailability, and reduce toxicity, especially when combined with FUSBO.

Potential for biologics and gene therapy: FUSBO may enable delivery of monoclonal antibodies, single-chain fragment variable antibodies, and adeno-associated virus (AAV) gene therapies to the CNS, overcoming size and immune barriers.

Safety and technical considerations: FUSBO is generally safe in animal and early human studies, but potential risks include microglial activation, microhemorrhage, and neuronal suppression at high intensities; optimal parameters for various drugs and delivery systems remain to be established.

Outlook and clinical promise: FUSBO combined with advanced drug delivery particles could transform chronic pain management by bypassing the BBB, expanding the range of usable therapies, and improving the therapeutic window, but clinical trials are needed to confirm efficacy and safety in humans.

Posted on

Avoidance of Major Vascular Injury in Transcranial Brain Tumor Surgery Using Real-Time Doppler Navigation

Operative Neurosurgery 29:633–638, 2025

This clinical technical note and case series evaluates real-time Doppler probe navigation during transcranial craniotomy for brain tumor resection, describing technique, operative workflow, and outcomes from 501 operations where the Doppler was used. The authors report a low rate of major vessel injury (<1%) and discuss how Doppler guidance complements neuronavigation and ultrasound as tumor resection progresses and brain shift reduces image accuracy.

The paper details patient selection, surgical approaches, probe specifications and intraoperative use, illustrates three case examples with video, and analyzes stroke and infarction rates attributable to vasospasm or small-vessel injury. Limitations include retrospective design and variable probe penetrance; the authors recommend routine Doppler adjunctive use for tumors encasing or adherent to major arteries.

Posted on

Intraoperative ultrasound and magnetic resonance comparative analysis in brain tumor surgery: a valuable tool to flatten ultrasound’s learning curve

Acta Neurochirurgica (2024) 166:337

Intraoperative ultrasound (IOUS) is a profitable tool for neurosurgical procedures’ assistance, especially in neuro-oncology. It is a rapid, ergonomic and reproducible technique. However, its known handicap is a steep learning curve for neurosurgeons. Here, we describe an interesting postoperative analysis that provides extra feedback after surgery, accelerating the learning process.

Method We conducted a descriptive retrospective unicenter study including patients operated from intra-axial brain tumors using neuronavigation (Curve, Brainlab) and IOUS (BK-5000, BK medical) guidance. All patients had preoperative Magnetic Resonance Imaging (MRI) prior to tumor resection. During surgery, 3D neuronavigated IOUS studies (n3DUS) were obtained through craniotomy N13C5 transducer’s integration to the neuronavigation system. At least two n3DUS studies were obtained: prior to tumor resection and at the resection conclusion. A postoperative MRI was performed within 48 h. MRI and n3DUS studies were posteriorly fused and analyzed with Elements (Brainlab) planning software, permitting two comparative analyses: preoperative MRI compared to pre-resection n3DUS and postoperative MRI to post-resection n3DUS. Cases with incomplete MRI or n3DUS studies were withdrawn from the study.

Results From April 2022 to March 2024, 73 patients were operated assisted by IOUS. From them, 39 were included in the study. Analyses comparing preoperative MRI and pre-resection n3DUS showed great concordance of tumor volume (p < 0,001) between both modalities. Analysis comparing postoperative MRI and post-resection n3DUS also showed good concordance in residual tumor volume (RTV) in cases where gross total resection (GTR) was not achieved (p < 0,001). In two cases, RTV detected on MRI that was not detected intra-operatively with IOUS could be reviewed in detail to recheck its appearance.

Conclusions Post-operative comparative analyses between IOUS and MRI is a valuable tool for novel ultrasound users, as it enhances the amount of feedback provided by cases and could accelerate the learning process, flattening this technique’s learning curve.

Posted on

Challenges with segmenting intraoperative ultrasound for brain tumours

Challenges with segmenting intraoperative ultrasound for brain tumours

Acta Neurochirurgica (2024) 166:317

Addressing the challenges that come with identifying and delineating brain tumours in intraoperative ultrasound. Our goal is to both qualitatively and quantitatively assess the interobserver variation, amongst experienced neuro-oncological intraoperative ultrasound users (neurosurgeons and neuroradiologists), in detecting and segmenting brain tumours on ultrasound. We then propose that, due to the inherent challenges of this task, annotation by localisation of the entire tumour mass with a bounding box could serve as an ancillary solution to segmentation for clinical training, encompassing margin uncertainty and the curation of large datasets.

Methods – 30 ultrasound images of brain lesions in 30 patients were annotated by 4 annotators – 1 neuroradiologist and 3 neurosurgeons. The annotation variation of the 3 neurosurgeons was first measured, and then the annotations of each neurosurgeon were individually compared to the neuroradiologist’s, which served as a reference standard as their segmentations were further refined by cross-reference to the preoperative magnetic resonance imaging (MRI). The following statistical metrics were used: Intersection Over Union (IoU), Sørensen-Dice Similarity Coefficient (DSC) and Hausdorff Distance (HD). These annotations were then converted into bounding boxes for the same evaluation. Results – There was a moderate level of interobserver variance between the neurosurgeons [ IoU : 0.789, DSC : 0.876, H D : 103.227 ] and a larger level of variance when compared against the MRI-informed reference standard annotations by the neuroradiologist, mean across annotators [ IoU : 0.723, DSC : 0.813, H D : 115.675 ] . After converting the segments to bounding boxes, all metrics improve, most significantly, the interquartile range drops by [ IoU : 37%, DSC : 41%, H D : 54% ] .

Conclusion This study highlights the current challenges with detecting and defining tumour boundaries in neuro-oncological intraoperative brain ultrasound. We then show that bounding box annotation could serve as a useful complementary approach for both clinical and technical reasons.

Posted on

Intraoperative ultrasound and magnetic resonance comparative analysis in brain tumor surgery: a valuable tool to flatten ultrasound’s learning curve

Acta Neurochirurgica (2024) 166:337

Intraoperative ultrasound (IOUS) is a profitable tool for neurosurgical procedures’ assistance, especially in neuro-oncology. It is a rapid, ergonomic and reproducible technique. However, its known handicap is a steep learning curve for neurosurgeons. Here, we describe an interesting postoperative analysis that provides extra feedback after surgery, accelerating the learning process.

Method We conducted a descriptive retrospective unicenter study including patients operated from intra-axial brain tumors using neuronavigation (Curve, Brainlab) and IOUS (BK-5000, BK medical) guidance. All patients had preoperative Magnetic Resonance Imaging (MRI) prior to tumor resection. During surgery, 3D neuronavigated IOUS studies (n3DUS) were obtained through craniotomy N13C5 transducer’s integration to the neuronavigation system. At least two n3DUS studies were obtained: prior to tumor resection and at the resection conclusion. A postoperative MRI was performed within 48 h. MRI and n3DUS studies were posteriorly fused and analyzed with Elements (Brainlab) planning software, permitting two comparative analyses: preoperative MRI compared to pre-resection n3DUS and postoperative MRI to post-resection n3DUS. Cases with incomplete MRI or n3DUS studies were withdrawn from the study.

Results From April 2022 to March 2024, 73 patients were operated assisted by IOUS. From them, 39 were included in the study. Analyses comparing preoperative MRI and pre-resection n3DUS showed great concordance of tumor volume (p < 0,001) between both modalities. Analysis comparing postoperative MRI and post-resection n3DUS also showed good concordance in residual tumor volume (RTV) in cases where gross total resection (GTR) was not achieved (p < 0,001). In two cases, RTV detected on MRI that was not detected intra-operatively with IOUS could be reviewed in detail to recheck its appearance.

Conclusions Post-operative comparative analyses between IOUS and MRI is a valuable tool for novel ultrasound users, as it enhances the amount of feedback provided by cases and could accelerate the learning process, flattening this technique’s learning curve.

Posted on

Navigated intraoperative ultrasound in neuro-oncology: volumetric accuracy and correlation with high-field MRI

J Neurosurg 141:79–88, 2024

The use of intraoperative techniques to detect residual tumors has recently become increasingly important. Intraoperative MRI has long been considered the gold standard; however, it is not widely used because of high equipment costs and long acquisition times. Consequently, real-time intraoperative ultrasound (ioUS), which is much less expensive than MRI, has gained popularity. The aim of the present study was to evaluate the capacity of ioUS to accurately determine the primary tumor volume and detect residual tumors.

METHODS A prospective study of adult patients who underwent surgery for intra-axial brain tumors between November 2017 and October 2020 was performed. Navigated intraoperative ultrasound (nioUS) of the brain was used to guide tumor resection and to detect the presence of residual disease. Both convex (5–8 MHz) and linear array (6–13 MHz) probes were used. Tumor volume and residual disease were measured with nioUS and compared with MR images. A linear regression model based on a machine learning pipeline and a Bland-Altman analysis were used to assess the accuracy of nioUS versus MRI.

RESULTS Eighty patients (35 females and 45 males) were included. The mean age was 58 years (range 25–80 years). A total of 88 lesions were evaluated; there were 64 (73%) gliomas, 19 (21.6%) metastases, and 5 (5.7%) other tumors, mostly located in the frontal (41%) and temporal (27%) lobes. Most of the tumors (75%) were perfectly visible on ioUS (grade 3, Mair grading system), except for those located in the insular lobe (grade 2). The regression model showed a nearly perfect correlation (R 2 = 0.97, p < 0.001) between preoperative tumor volumes from both MRI and nioUS. Ultrasonographic visibility significantly influenced this correlation, which was stronger for highly visible (grade 3) tumors (p = 0.01). For residual tumors, the correlation between postoperative MRI and nioUS was weaker (R 2 = 0.78, p < 0.001) but statistically significant. The Bland-Altman analysis showed minimal bias between the two techniques for pre- and postoperative scenarios, with statistically significant results for the preoperative concordance.

CONCLUSIONS The authors’ findings show that most brain tumors are well delineated by nioUS and almost perfectly correlated with MRI-based measurements both pre- and postoperatively. These data support the hypothesis that nioUS is a reliable intraoperative technique that can be used for real-time monitoring of brain tumor resections and to perform volumetric analysis of residual disease.

Posted on

First Experience With Postoperative Transcranial Ultrasound Through Sonolucent Burr Hole Covers in Adult Hydrocephalus Patients

Neurosurgery 92:382–390, 2023

Managing patients with hydrocephalus and cerebrospinal fluid (CSF) disorders requires repeated head imaging. In adults, it is typically computed tomography (CT) or less commonly magnetic resonance imaging (MRI). However, CT poses cumulative radiation risks and MRI is costly. Ultrasound is a radiation-free, relatively inexpensive, and optionally point-of-care alternative, but is prohibited by very limited windows through an intact skull.

OBJECTIVE: To describe our initial experience with transcutaneous transcranial ultrasound through sonolucent burr hole covers in postoperative hydrocephalus and CSF disorder patients.

METHODS: Using cohort study design, infection and revision rates were compared between patients who underwent sonolucent burr hole cover placement during new ventriculoperitoneal shunt placement and endoscopic third ventriculostomy over the 1-year study time period and controls from the period 1 year before. Postoperatively, trans-burr hole ultrasound was performed in the clinic, at bedside inpatient, and in the radiology suite to assess ventricular anatomy.

RESULTS: Thirty-seven patients with sonolucent burr hole cover were compared with 57 historical control patients. There was no statistically significant difference in infection rates between the sonolucent burr hole cover group (1/37, 2.7%) and the control group (0/57, P = .394). Revision rates were 13.5% vs 15.8% (P = 1.000), but no revisions were related to the burr hole or cranial hardware.

CONCLUSION: Trans-burr hole ultrasound is feasible for gross evaluation of ventricular caliber postoperatively in patients with sonolucent burr hole covers. There was no increase in infection rate or revision rate. This imaging technique may serve as an alternative to CT and MRI in the management of select patients with hydrocephalus and CSF disorders.

Posted on

Ultrasonic spine surgery for every thoracic disc herniation

J Neurosurg Spine 36:800–808, 2022

Thoracic disc herniations (TDHs) are a challenging pathology. A variety of surgical techniques have been used to achieve spinal cord decompression. This series elucidates the versatility, efficacy, and safety of the partial transpedicular approach with the use of intraoperative ultrasound and ultrasonic aspiration for resection of TDHs of various sizes, locations, and consistencies. This technique can be deployed to safely remove all TDHs.

METHODS A retrospective review was performed of patients who underwent a thoracic discectomy via the partial transpedicular approach between January 2014 and December 2020 by a single surgeon. Variables reviewed included demographics, perioperative imaging, and functional outcome scores.

RESULTS A total of 43 patients (53.5% female) underwent 54 discectomies. The most common presenting symptoms were myelopathy (86%), motor weakness (72%), and sensory deficit (65%) with a symptom duration of 10.4 ± 11.6 months. A total of 21 (38.9%) discs were fully calcified on imaging and 15 (27.8%) were partially calcified. A total of 36 (66.7%) were giant TDHs (> 40% canal compromise). The average operative time was 197.2 ± 77.1 minutes with an average blood loss of 238.8 ± 250 ml. Six patients required ICU stays. Hospital length of stay was 4.40 ± 3.4 days. Of patients with follow-up MRI, 38 of 40 (95%) disc levels demonstrated < 20% residual disc. Postoperative Frankel scores (> 3 months) were maintained or improved for all patients, with 28 (65.1%) patients having an increase of 1 grade or more on their Frankel score. Six (14%) patients required repeat surgery, 2 of which were due to reherniation, 2 were from adjacent-level herniation, and 2 others were from wound problems. Patients with calcified TDHs had similar improvement in Frankel grade compared to patients without calcified TDH. Additionally, improvement in intraoperative neuromonitoring was associated with a greater improvement in Frankel grade.

CONCLUSIONS The authors demonstrate a minimally disruptive, posterior approach that uses intraoperative ultrasound and ultrasonic aspiration with excellent outcomes and a complication profile similar to or better than other reported case series. This posterior approach is a valuable complement to the spine surgeon’s arsenal for the confident tackling of all TDHs.

Posted on

3D ultrasound–guided resection of low-grade gliomas: principles and clinical examples

Neurosurg Focus 47 (6):E9, 2019

3D ultrasound (US) is a convenient tool for guiding the resection of low-grade gliomas, seemingly without deterioration in patients’ quality of life.

This article offers an update of the intraoperative workflow and the general principles behind the 3D US acquisition of high-quality images.

The authors also provide case examples illustrating the technique in two small mesial temporal lobe lesions and in one insular glioma. Due to the ease of acquiring new images for navigation, the operations can be guided by updated image volumes throughout the entire course of surgery.

The high accuracy offered by 3D US systems, based on nearly realtime images, allows for precise and safe resections. This is especially useful when an operation is performed through very narrow transcortical corridors.

Posted on

Ultrasound-guided brain surgery: echographic visibility of different pathologies and surgical applications in neurosurgical routine

Acta Neurochirurgica (2018) 160:1175–1185

The use of intraoperative ultrasound (iUS) has increased in the last 15 years becoming a standard tool in many neurosurgical centers. Our aim was to assess the utility of routine use of iUS during various types of intracranial surgery. We reviewed our series to assess ultrasound visibility of different pathologies and iUS applications during the course of surgery.

Materials and methods This is a retrospective review of 162 patients who underwent intracranial surgery with assistance of the iUS guidance system (SonoWand). Pathologic categories were neoplastic (135), vascular (20), infectious (2), and CSF related (5). Ultrasound visibility was assessed using the Mair classification, a four-tiered grading system that considers the echogenicity of the lesion and its border visibility (from 0 to 3; grade 0, pathology not visible; grade 3, visible with clear border with normal tissue). iUS applications included lesion localization, approach planning to deep-seated lesions, and lesion removal.

Results All pathologies were visible on iUS except one aneurysm. On average, extra-axial tumors were identified more easily and had clearer limits compared to intra-axial tumors (extra-axial 17%grade 2, 83%grade 3; intra-axial 5.5% grade 1, 46.5%grade 2, 48% grade 3). iUS provided precise and safe transcortical trajectories to deep-seated lesions (71 patients; tumors, hemangiomas, ICHs); iUS was judged to be less useful to approach skull base tumors and aneurysms. iUS was used to judge extent of resection in 152 cases; surgical artifacts reduced sonographic visibility in 25 cases: extent of resection was correctly checked in 127 patients (53 gliomas, 15 metastases, 39 meningiomas, 4 schwannomas, 4 sellar region tumors, 6 hemangiomas, 3 AVMs, 2 abscesses).

Conclusions iUS was highly sensitive in detecting all types of pathology, was safe and precise in planning trajectories to intraparenchymal lesions (including minimally mini-invasive approaches), and was accurate in checking extent of resection in more than 80% of cases. iUS is a versatile and feasible tool; it could improve safety and its use may be considered in routine intracranial surgery.

Posted on

USim: A New Device and App for Case-Specific, Intraoperative Ultrasound Simulation and Rehearsal in Neurosurgery

Operative Neurosurgery 14:572–578, 2018

Intraoperative ultrasound (iUS) is an excellent aid for neurosurgeons to perform better and safer operations thanks to real time, continuous, and high-quality intraoperative visualization. OBJECTIVE: To develop an innovative training method to teach how to perform iUS in neurosurgery.

METHODS: Patients undergoing surgery for different brain or spine lesions were iUS scanned (before opening the dura) in order to arrange a collection of 3-dimensional, US images; this set of data was matched and paired to preoperatively acquired magnetic resonance images in order to create a library of neurosurgical cases to be studied offline for training and rehearsal purposes. This new iUS training approach was preliminarily tested on 14 European neurosurgery residents, who participated at the 2016 European Association of Neurosurgical Societies Training Course (Sofia, Bulgaria).

RESULTS: USim was developed by Camelot and the Besta NeuroSim Center as a dedicated app that transforms any smartphone into a “virtual US probe,” in order to simulate iUS applied to neurosurgery on a series of anonymized, patient-specific cases of different central nervous system tumors (eg, gliomas, metastases, meningiomas) for education, simulation, and rehearsal purposes. USim proved to be easy to use and allowed residents to quickly learn to handle a US probe and interpret iUS semiotics.

CONCLUSION: USim could help neurosurgeons learn neurosurgical iUS safely. Furthermore, neurosurgeons could simulate many cases, of different brain/spinal cord tumors, that resemble the specific cases they have to operate on. Finally, the library of caseswould be continuously updated, upgraded, and made available to neurosurgeons.

Posted on

Noninvasive neuromodulation and thalamic mapping with low-intensity focused ultrasound

J Neurosurg 128:875–884, 2018

Ultrasound can be precisely focused through the intact human skull to target deep regions of the brain for stereotactic ablations. Acoustic energy at much lower intensities is capable of both exciting and inhibiting neural tissues without causing tissue heating or damage. The objective of this study was to demonstrate the effects of low-intensity focused ultrasound (LIFU) for neuromodulation and selective mapping in the thalamus of a large-brain animal.

METHODS Ten Yorkshire swine (Sus scrofa domesticus) were used in this study. In the first neuromodulation experiment, the lemniscal sensory thalamus was stereotactically targeted with LIFU, and somatosensory evoked potentials (SSEPs) were monitored. In a second mapping experiment, the ventromedial and ventroposterolateral sensory thalamic nuclei were alternately targeted with LIFU, while both trigeminal and tibial evoked SSEPs were recorded. Temperature at the acoustic focus was assessed using MR thermography. At the end of the experiments, all tissues were assessed histologically for damage.

RESULTS LIFU targeted to the ventroposterolateral thalamic nucleus suppressed SSEP amplitude to 71.6% ± 11.4% (mean ± SD) compared with baseline recordings. Second, we found a similar degree of inhibition with a high spatial resolution (~ 2 mm) since adjacent thalamic nuclei could be selectively inhibited. The ventromedial thalamic nucleus could be inhibited without affecting the ventrolateral nucleus. During MR thermography imaging, there was no observed tissue heating during LIFU sonications and no histological evidence of tissue damage.

CONCLUSIONS These results suggest that LIFU can be safely used to modulate neuronal circuits in the central nervous system and that noninvasive brain mapping with focused ultrasound may be feasible in humans.

Proudly powered by WordPress